Integrated Universal
Artificial Intelligence
for Every Step of Pharmaceutical Research and Development
Our Mission is to accelerate drug discovery and drug development by continuously inventing and deploying new artificial intelligence technologies
We provide artificial intelligence solutions to the top industry players and use these solutions internally to develop a pipeline of therapeutic programs in cancer, fibrosis, antiinfectives, immunology, and senescence

We aspire to be a leader in the field of deep learning for drug discovery and development by relentlessly innovating, publishing proofs of concept in peer-reviewed academic journals, and delivering great AI software for the top industry experts
Introducing fully-integrated drug discovery software suite
AI Pharma Pipeline
We developed a comprehensive drug discovery engine, which utilizes millions of samples and multiple data types to discover signatures of disease and identify the most promising targets for billions of molecules that already exist or can be generated
de novo with the desired set of parameters.
Over 150 Academic
and Industry Collaborators Worldwide

We have a great pleasure to work with the leading companies and institutions
to provide next-level solutions for drug discovery and biomarker development.
We have over 120 scientists with over 80 AI scientists mostly hired through hackathons and competitions worldwide in Rockville, Oxford, Warsaw, Brussels, Shanghai, Taipei, and Hong Kong.

We have strong medicinal chemistry and pre-clinical teams
Contact us:
Insilico Medicine

307A, Core Building 1, 1 Science Park East Avenue, Hong Kong Science Park,
Pak Shek Kok, Hong Kong